Key facts
- It has raised $2.0M; the latest was Later Stage VC ($2.0M) in Mar 2026.
- Notable investors include Hanyang University Technology Holdings, NH Venture Investment, We Ventures (Korea).
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Endovision
- ·The full record, as it builds
Funding rounds
No funding rounds for Endovision are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Endovision
Developer of medical devices intended to improve human health and medical treatments. The company studies, develops, and manufactures a wide range of products, mainly biomaterials, spinal endoscopes, arthroscopes, endoscopes, laparoscopes, and gynecologic, with continuous research and development activities for the next generation and advanced bio and mechanical medical device market, providing the healthcare industry with safe and satisfactory products and services.
- Sector
- Healthcare
- HQ
- Daegu, South Korea
- Founded
- 2013
- Employees
- 54
- Website
- endovision.co.kr/
- Ownership
- Privately Held (backing)
Endovision doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Endovision shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Endovision in its N-PORT filings yet. We sweep new filings monthly.